Differences Seen in Composition of Gut Microbiome in MG Patients
Differences in gut bacteria composition in people with myasthenia gravis (MG) may be a promising avenue to explore in…
Articles by Marisa Wexler, MS
Calprotectin, Inflammatory Protein, May Be Biomarker of MG Severity
An inflammation-associated protein called calprotectin is present at abnormally high levels in the blood of people with myasthenia gravis…
MG Severity Linked With Female Sex, Obesity and Diagnostic Delay
Myasthenia gravis (MG) tends to be more severe in people who are female, obese, or who took a long…
Immunovant Will Use $200M Investment to Advance IMVT-1401
Immunovant will use a $200 million strategic investment from Roivant Sciences to advance IMVT-1401, its investigational therapy for…
Rare Case of MG Crisis Attributed to COVID-19 Vaccine
A very rare case of a myasthenia gravis (MG) crisis caused by the Moderna COVID-19 vaccine was described recently…
Rare 2030 Action Campaign Pushing for European Plan for Rare Diseases
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Immunovant Planning Pivotal Trial of IMVT-1401
Following a review of available clinical data, Immunovant has announced plans to resume clinical testing of the investigational medication…
Early Swallowing Difficulty Tied to Worse Outcomes
People with myasthenia gravis (MG) who have difficulty swallowing are more likely to have poor clinical outcomes, according to…
#AANAM – Fatigue Common in MG, Even for People With Milder Forms
Editor’s note: The Myasthenia Gravis News team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
#MDA2021 – Infection Risk Found Unaffected by Long-term Soliris Use
When used over long periods of time, Soliris (eculizumab) does not increase the risk of infections in people with…